Red ginger-extract nanoemulsion modulates high blood pressure in rats by regulating angiotensin-converting enzyme production
- PMID: 33642802
- PMCID: PMC7896892
- DOI: 10.14202/vetworld.2021.176-181
Red ginger-extract nanoemulsion modulates high blood pressure in rats by regulating angiotensin-converting enzyme production
Abstract
Background and aim: Red ginger (RG) has reportedly been used in folk medicine for the management and prevention of hypertension. One of the hypertension study models in experimental animals is the unilateral ureteral obstruction (UUO). This study aimed at evaluating the effect of RG-extract (RGE) nanoemulsion on UUO-induced hypertension and angiotensin-converting enzyme (ACE) production in rats.
Materials and methods: RG was extracted using ethanol, combined with virgin coconut oil, polysorbate 80, and polyethylene glycol 400 to form the oil phase. The particle sizes of RGE nanoemulsions were analyzed using a particle size analyzer. The UUO method was used to induce chronic kidney disease in rats (504 mg/200 g and 360 mg/200 g b/w per oral for 7 days). The systolic and diastolic blood pressure was determined non-invasively in conscious state by tail plethysmography using an automated blood pressure monitor. ACE in serum was measured using enzyme-linked immunosorbent assay.
Results: The RGE nanoemulsions exhibited a particle size of32.8 nm and a polydispersity index (PI) of 0.268, indicating a homogenous nanoemulsion. UUO rats treated with RGE nanoemulsion (360 mg/200 g b/w) experienced a significant decrease in both their systolic blood pressure (p<0.05) from 142±1 mmHg to 107±6 mmHg and their diastolic blood pressure from 106±1 mmHg to 84±4 mmHg. Furthermore, treatment with RGE resulted in a 10.80% decrease in the level of ACE.
Conclusion: The size and the PI of the RGE used in this study suggest a stable and effective distribution of the particle size in the emulsions. RGE nanoemulsions at the dose of 360 mg/200 g bw can be used as potential ACE inhibitors because they were found to decrease the blood pressure of hypertensive UUO rats.
Keywords: angiotensin-converting enzyme; blood pressure; nanoemulsion; red ginger; unilateral ureteral obstruction.
Copyright: © Hanifah, et al.
Figures
Similar articles
-
Virgin olive oil (unfiltered) extract contains peptides and possesses ACE inhibitory and antihypertensive activity.Clin Nutr. 2020 Apr;39(4):1242-1249. doi: 10.1016/j.clnu.2019.05.016. Epub 2019 May 23. Clin Nutr. 2020. PMID: 31178246
-
Nanoemulsion strategy for olmesartan medoxomil improves oral absorption and extended antihypertensive activity in hypertensive rats.Colloids Surf B Biointerfaces. 2014 Mar 1;115:286-94. doi: 10.1016/j.colsurfb.2013.12.016. Epub 2013 Dec 16. Colloids Surf B Biointerfaces. 2014. PMID: 24388859
-
Cardiovascular status following combined angiotensin-converting enzyme and AT1 receptor inhibition in conscious spontaneously hypertensive rats.Clin Exp Pharmacol Physiol. 2003 May-Jun;30(5-6):317-23. doi: 10.1046/j.1440-1681.2003.03837.x. Clin Exp Pharmacol Physiol. 2003. PMID: 12859420
-
The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.Can J Cardiol. 2010 May;26(5):249-58. doi: 10.1016/s0828-282x(10)70379-2. Can J Cardiol. 2010. PMID: 20485689 Free PMC article. Review.
-
The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2--therapy.Can J Cardiol. 2009 May;25(5):287-98. doi: 10.1016/s0828-282x(09)70492-1. Can J Cardiol. 2009. PMID: 19417859 Free PMC article. Review.
Cited by
-
A Revolutionary Blueprint for Mitigation of Hypertension via Nanoemulsion.Biomed Res Int. 2022 Apr 14;2022:4109874. doi: 10.1155/2022/4109874. eCollection 2022. Biomed Res Int. 2022. PMID: 35463984 Free PMC article. Review.
-
Folic acid-induced animal model of kidney disease.Animal Model Exp Med. 2021 Nov 24;4(4):329-342. doi: 10.1002/ame2.12194. eCollection 2021 Dec. Animal Model Exp Med. 2021. PMID: 34977484 Free PMC article. Review.
References
-
- Balasubramanian S. Progression of chronic kidney disease:Mechanisms and interventions in retardation. Apollo Med. 2013;10(1):19–28.
-
- Shah S.V, Baliga R, Rajapurkar M, Fonseca V.A. Oxidants in chronic kidney disease. J. Am. Soc. Nephrol. 2007;18(1):16–28. - PubMed
-
- Klahr S, Morrissey J. Obstructive nephropathy and renal fibrosis. Am. J. Physiol. Renal Physiol. 2002;283(5):F861–F875. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous